Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Is Canopy Growth a good stock to buy?

Canopy Growth Corp. (TSX:WEED) holds a prominent position in the Canadian cannabis industry, but is it a good stock to buy? Initially, the stock experienced remarkable growth, driven by the anticipation surrounding the legalization of recreational cannabis in ...
Jonathon Brown | December 13, 2023 |

EQS Group, EXMceuticals, Media and Games Invest - Buy recommendations from the experts

Analysts' reports on listed companies serve investors as an external source of information. As a rule, research houses publish their recommendations in connection with financing, the publication of financial statements or in order to increase awareness. The information is usua...
Mario Hose | August 20, 2020 |

'Topline Beat, All Eyes on Potential M&A' by Health Technologies Firm

An update on the Canadian company, including its Q2/19 results and its next expected catalyst, is provided in a Haywood report. In an Aug. 23 research note, analyst Daniel Rosenberg reported that his firm Haywood increased its price target on WELL Health Technologies...
Streetwise Reports | August 28, 2019 |

Gold Explorer and Developer 'On Track to Repeat Atlantic Gold Success'

Observations and takeaways from a visit to the company's Bulgaria properties are given in a Haywood report. In an Aug. 21 research note, Haywood analyst Mick Carew reported that Velocity Minerals Ltd. (VLC:TSX.V; VLCJF:OTCQB) is "is on track to repeat Atlantic Gold ...
Streetwise Reports | August 30, 2019 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

Explorer Extends Copper-Gold Mineralization to Depth at Flagship B.C. Project

The key points regarding recent drill results and next steps are presented in a Haywood report. In a Sept. 4 research note, Haywood analyst Mick Carew reported that GT Gold Corp.'s (GTT:TSX.V) recent drill results from the Saddle North discovery at its Tatogga proje...
Streetwise Reports | September 20, 2019 |

Recent Drilling at Ecuador Project Returns 'Impressive' Results

The drill results are relayed and interpreted in a Haywood report. In a Sept. 27 research note, Haywood analyst Geordie Mark reported that Luminex Resources Corp. (LR:TSX.V; LUMIF:OTCMKTS) continues to show continuity of high-grade epithermal gold mineralization at ...
Streetwise Reports | October 4, 2019 |

Canadian Gold Miner Achieves 'Strong Q3/19 Operationally'

The company's performance during the quarter is covered in a Haywood report. In a Nov. 1 research note, Haywood analyst Kerry Smith reported that Equinox Gold Corp. (EQX:TSX.V) , in its first quarter of commercial production at the Aurizona mine, "delivered a solid Q...
Streetwise Reports | November 22, 2019 |

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...
Streetwise Reports | November 27, 2019 |

Canada Asset 'Sale Helps Company Focus on Mexico'

The specifics and benefits of the transaction are addressed in a ROTH Capital Partners report. In a Nov. 22 research note, ROTH Capital Partners analyst Joe Reagor reported that Avino Silver & Gold Mines Ltd. (ASM:TSX.V; ASM:NYSE.MKT; GV6:FSE) agreed to sell its Bra...
Streetwise Reports | December 2, 2019 |
1 2 3 4